Organization and Description of Business (Details Narrative) - $ / shares |
Apr. 16, 2021 |
Apr. 16, 2021 |
Mar. 23, 2020 |
---|---|---|---|
Membership Interest Purchase Agreement [Member] | |||
Ownership pecentage | 100.00% | ||
Subsequent Event [Member] | Merger Agreement [Member] | |||
Option to purchase shares of common stock | 4,188,315 | ||
MyMD Pharmaceuticals (Florida), Inc [Member] | Subsequent Event [Member] | |||
Common stock par value | $ 0.001 | $ 0.001 | |
Exchange ratio price per shares | $ 0.7718 | $ 0.7718 | |
Reverse stock split | 1-for-2 reverse stock split | ||
Warrants to purchase | 986,486 | 986,486 | |
Option to purchase shares of common stock | 4,188,315 | ||
Ownership pecentage | 22.95% | 22.95% | |
MyMD Pharmaceuticals (Florida), Inc [Member] | Subsequent Event [Member] | Merger Agreement [Member] | |||
Ownership pecentage | 77.05% | 77.05% |
X | ||||||||||
- Definition Exchange ratio price per shares. No definition available.
|
X | ||||||||||
- Definition Option to purchase shares of common stock. No definition available.
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|